companydata.dkEmbryoTrans Biotech ApS: Financial statements 2016
CVR: 36701676
EmbryoTrans Biotech ApS (CVR 36701676) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,767,468 and a net result of DKK 132,445. Equity amounted to DKK 454,997. The solvency ratio was 54.3%.
- Gross Profit
- 1,767,468 kr.
- Profit/Loss
- 132,445 kr.
- Equity
- 454,997 kr.
- Total Assets
- 838,133 kr.
How creditworthy is EmbryoTrans Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
EmbryoTrans Biotech ApS has published its interim report for the period March 23, 2015 – December 31, 2015.
As of February 26, 2016, Lotte Bjørg Strøbech has joined the board of directors of EmbryoTrans Biotech ApS.
As of February 26, 2016, Ulrik Bangsbo Hansen is registered as chairman of EmbryoTrans Biotech ApS.
About EmbryoTrans Biotech ApS
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015 and dissolved in 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company has 4 employees. In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity amounted to DKK 242,326.